Blue double light. Improved method of phototherapy

Area of Science:

• Neonatal Medicine
• Pediatric Phototherapy
• Hemolytic Disease of the Newborn

Background:

• Rhesus haemolytic disease is a serious condition in newborns, often requiring intervention to manage hyperbilirubinemia.
• Phototherapy is a standard treatment, but its efficacy can vary.
• Optimizing phototherapy delivery is crucial for improving infant outcomes and reducing the need for more invasive procedures.

Purpose of the Study:

• To compare the effectiveness of blue double light phototherapy versus traditional white light phototherapy in treating rhesus haemolytic disease in neonates.
• To assess the impact of different phototherapy methods on the requirement for exchange transfusions.

Main Methods:

• A comparative study involving 70 newborn infants diagnosed with rhesus haemolytic disease.
• Group 1 (28 cases): Received phototherapy using blue light on both sides of the infant.
• Group 2 (42 cases): Received traditional white light phototherapy on one side of the infant.

Main Results:

• The number of exchange transfusions required after the initial 12 hours of life was significantly lower in the group treated with blue double light phototherapy.
• This indicates a more rapid and effective reduction of bilirubin levels with the blue double light method.

Conclusions:

• Blue double light phototherapy appears to be a superior method for treating rhesus haemolytic disease in newborn infants compared to traditional white light.
• The findings suggest that optimizing light delivery, such as using blue double light, can improve treatment outcomes and potentially decrease the need for exchange transfusions.